CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-21 | BAKER BROS. ADVISORS LP Director | Purchase | +2,124 | $187.24 | $398K | 1,612,339 |
| 2023-11-21 | BAKER BROS. ADVISORS LP Director | Purchase | +388 | $187.27 | $73K | 171,769 |
| 2023-11-21 | BAKER BROS. ADVISORS LP Director | Purchase | +4,712 | $187.27 | $882K | 1,617,051 |
| 2023-11-21 | BAKER BROS. ADVISORS LP Director | Purchase | +1,076 | $188.32 | $203K | 172,845 |
| 2023-11-21 | BAKER BROS. ADVISORS LP Director | Purchase | +13,011 | $188.32 | $2.5M | 1,630,062 |
| 2023-11-21 | BAKER BROS. ADVISORS LP Director | Purchase | +1,117 | $188.46 | $211K | 173,962 |
| 2023-11-21 | BAKER BROS. ADVISORS LP Director | Purchase | +13,505 | $188.46 | $2.5M | 1,643,567 |
| 2023-11-21 | BAKER BROS. ADVISORS LP Director | Purchase | +1,291 | $188.70 | $244K | 175,253 |
| 2023-11-21 | BAKER BROS. ADVISORS LP Director | Purchase | +15,620 | $188.70 | $2.9M | 1,659,187 |
| 2023-11-21 | BAKER BROS. ADVISORS LP Director | Purchase | +655 | $190.14 | $125K | 175,908 |
| 2023-11-21 | BAKER BROS. ADVISORS LP Director | Purchase | +7,917 | $190.14 | $1.5M | 1,667,104 |
| 2023-11-20 | Huntsman Carole Chief Commercial Officer | Grant or award | +7,834 | 7,834 | ||
| 2023-11-20 | Huntsman Carole Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +10,077 | 10,077 | ||
| 2023-11-20 | BAKER BROS. ADVISORS LP Director | Purchase | +153 | $181.93 | $28K | 169,565 |
| 2023-11-20 | BAKER BROS. ADVISORS LP Director | Purchase | +1,847 | $181.93 | $336K | 1,590,388 |
| 2023-11-20 | BAKER BROS. ADVISORS LP Director | Purchase | +579 | $183.40 | $106K | 170,144 |
| 2023-11-20 | BAKER BROS. ADVISORS LP Director | Purchase | +7,010 | $183.40 | $1.3M | 1,597,398 |
| 2023-11-20 | BAKER BROS. ADVISORS LP Director | Purchase | +100 | $185.87 | $19K | 170,244 |
| 2023-11-20 | BAKER BROS. ADVISORS LP Director | Purchase | +1,206 | $185.87 | $224K | 1,598,604 |
| 2023-11-20 | BAKER BROS. ADVISORS LP Director | Purchase | +405 | $187.35 | $76K | 170,649 |
Page 43 of 82 · 1,629 trades